Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Creb5 establishes the competence for Prg4 expression in articular cartilage

ABSTRACT: Zhang et al. identify Creb5 as a transcription factor that is required for induction of Prg4 expression by TGFbeta and EGFR ligands. They show that Creb5 directly binds to two Prg4 promoter-proximal regulatory elements, working together with a more distal regulatory element to drive induction of Prg4 by TGFbeta. These findings provide new insight into the molecular regulation of Prg4 expression in superficial zone articular chondrocytes.

ORGANISM(S): Bos taurus

PROVIDER: GSE132379 | GEO | 2021/03/16

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Creb5 coordinates synovial joint formation with the genesis of articular cartilage

Project description:While prior work has established that articular cartilage arises from Prg4-expressing perichondrial cells, it is not clear how this process is specifically restricted to the perichondrium of synovial joints. We document that the transcription factor Creb5 is necessary to initiate the expression of signaling molecules that both direct the formation of synovial joints and guide perichondrial tissue to form articular cartilage instead of bone. Creb5 promotes the generation of articular chondrocytes from perichondrial precursors in part by inducing expression of Wif1, which blocks a Wnt5a autoregulatory loop in the perichondrium. Postnatal deletion of Creb5 in the articular cartilage leads to loss of both flat superficial zone articular chondrocytes coupled with a loss of both Prg4 and Wif1 expression; and a non-cell autonomous up-regulation of Ctgf. Our findings indicate that Creb5 promotes both joint formation and the subsequent development of articular chondrocytes by disrupting a Wnt5a positive-feedback loop in the perichondrium.

2022-11-07 | GSE181883 | GEO

Creb5 establishes the competence for Prg4 expression in articular cartilage

Project description:Creb5 establishes the competence for Prg4 expression in articular cartilage

| PRJNA547776 | ENA

Creb5 establishes the competence for Prg4 expression in articular cartilage.

Project description: Not available

| S-EPMC7955038 | biostudies-literature

The global gene expression profile of superficial zone articular cartilage in P1 wildtype and Prg4 transgenic mice

Project description:To examine the unbiased global gene expression of over-expression of Prg4 in superficial zone articular chondrocytes in mice. This approach allows us to define novel signaling changes caused by the over-expression of Prg4 in superficial zone articular chondrocytes Total RNA was isolated from superficial zone chondrocytes in P1 articular cartilage in hind limbs (n=3) by laser capture microdissection. Same tissue from wild type mice served as control

2013-06-24 | E-GEOD-43663 | biostudies-arrayexpress

The global gene expression profile of superficial zone articular cartilage in P1 wildtype and Prg4 transgenic mice

2013-06-24 | GSE43663 | GEO

Gene expression by CREB5 overexpression in LNCaP cells

Project description:The aim of this research was to confirm the regulatory effect of CREB5 on gene expression in the development of prostate cancer.

2022-10-10 | GSE186380 | GEO

CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer

Project description:Inhibition of androgen-receptor (AR)signaling is the foundation of therapeutic regimens for advanced prostate cancers. However, nearly all patientsdevelop resistance and some never respond. To identify genes that mediate resistance to androgen ablation therapy, we performed an open reading frame (ORF) expression screen of17,255 ORFs and found that the transcription factorCREB5robustly conferred resistance to androgen deprivation and AR inhibition by enzalutamide. CREB5 overexpressionincreased enzalutamide-resistance 45-fold, enhanced resistance of tumor xenografts. CREB5 expression was also essential for enzalutamide-resistance patient-derived organoids. In clinical mCRPC, CREB5is frequently amplified and itsoverexpression positively correlated with castration resistance gene signatures including those of MYC and cell cycle. Mechanistically, CREB5 directly interacted at AR binding sites andenhanced site-specific AR bindingin enzalutamide. This dysregulated expression of 393 AR target genes including MYC and CDK1.These observations identifyCREB5asadriver of enzalutamide-resistance in a subset of advancedprostate cancer.

2019-09-21 | GSE137775 | GEO

A novel CREB5/TOP1MT axis confers cisplatin resistance through inhibiting mitochondrial apoptosis in head and neck squamous cell carcinoma

Project description:Cisplatin resistance is one of the main causes of treatment failure and death of head and neck squamous cell carcinoma (HNSCC). In order to better understand the mechanism of cisplatin resistance and formulate effective treatment strategies, we identified differentially expressed genes related to cisplatin resistance by RNA sequencing, RT-PCR and immunoblotting. CREB5 was selected as the most significantly up-regulated gene in cisplatin resistant cells. Gain- and loss-of-function experiments were performed to detect the effect of CREB5 on cisplatin resistance and mitochondrial apoptosis in HNSCC. Chromatin immunoprecipitation (ChIP) assay, dual-luciferase reporter assay, and immunoblotting experiments were performed to explore the underlying mechanisms of CREB5.

2022-07-07 | GSE202030 | GEO

Mus musculus

Project description:TGFbeta Induction in Tumors

| PRJNA95047 | ENA

Semaglutide ameliorates cardiac remodeling by optimizing energy substrate utilization and through the Creb5/NR4a1 axis in male mice

Project description:Semaglutide (Sema) is a novel glucagon-like peptide-1 receptor (GLP-1R) agonist that is used clinically as a hypoglycemic and bariatric agent, as it regulates the energy metabolic process. In heart failure, mitochondrial oxidative phosphorylation substrates are altered, glycolysis is increased, and intracellular energy production is decreased. However, the responsiveness of Sema-regulated energy metabolism to the metabolic environment of cardiomyocytes stimulated by pressure burden remains unclear. Herein, we used transverse aortic constriction (TAC) surgery as the disease model. We found that Sema improved cardiac dysfunction and attenuated myocardial hypertrophy and fibrosis. This is manifested by reduced myocyte volume and interstitial collagen deposition. We found that Sema treatment maintains mitochondrial morphology and function under conditions of chronic stress load-mediated damage. Untargeted metabolomics analysis revealed that Sema ameliorated mitochondrial lesions and reduced lipid accumulation and ATP insufficiency by promoting glycolytic species products enter the tricarboxylic acid cycle (TCA) and increasing β-oxidation. Transcriptional profiling results revealed that Sema exerted its effects on myocardial energy metabolism by regulating Creb5/NR4a1 in the canonical PI3K/AKT pathway. Specifically, Sema reduced the expression of NR4a1 and its translocation from the nucleus to mitochondria. The disorders of mitochondrial function and myocardial glucolipid metabolism were significantly ameliorated after NR4a1 knockdown. Overall, Sema ameliorates myocardial glucose, lipid, and energy metabolism disorders by regulating Creb5/NR4a1, thereby protecting against pathological myocardial remodeling. This finding provides a new therapeutic agent for improving pathological myocardial remodeling based on energy metabolic switching.

2024-03-26 | GSE262105 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data